These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 16041261)
21. Complete absence of KSHV/HHV-8 in posttransplant lymphoproliferative disorders: an immunohistochemical and molecular study of 52 cases. Chen W; Huang Q; Zuppan CW; Rowsell EH; Cao JD; Weiss LM; Wang J Am J Clin Pathol; 2009 May; 131(5):632-9. PubMed ID: 19369621 [TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus infection and altered control of apoptotic pathways in posttransplant lymphoproliferative disorders. Ghigna MR; Reineke T; Rincé P; Schüffler P; El Mchichi B; Fabre M; Jacquemin E; Durrbach A; Samuel D; Joab I; Guettier C; Lucioni M; Paulli M; Tinguely M; Raphael M Pathobiology; 2013; 80(2):53-9. PubMed ID: 22868923 [TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes. Bräuninger A; Spieker T; Mottok A; Baur AS; Küppers R; Hansmann ML Eur J Immunol; 2003 Jun; 33(6):1593-602. PubMed ID: 12778477 [TBL] [Abstract][Full Text] [Related]
34. Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation. Montone KT; Litzky LA; Wurster A; Kaiser L; Bavaria J; Kotloff R; Palevsky H; Pietra GG; Tomaszewski JE Surgery; 1996 May; 119(5):544-51. PubMed ID: 8619211 [TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation. Chen DB; Song QJ; Chen YX; Chen YH; Shen DH Int J Hematol; 2013 Jan; 97(1):117-24. PubMed ID: 23255160 [TBL] [Abstract][Full Text] [Related]
37. A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival. Kinch A; Baecklund E; Backlin C; Ekman T; Molin D; Tufveson G; Fernberg P; Sundström C; Pauksens K; Enblad G Acta Oncol; 2014 May; 53(5):669-79. PubMed ID: 24164103 [TBL] [Abstract][Full Text] [Related]
38. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases]. Chen DB; Wang Y; Song QJ; Shen DH Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829 [TBL] [Abstract][Full Text] [Related]
39. Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders. Craig FE; Johnson LR; Harvey SA; Nalesnik MA; Luo JH; Bhattacharya SD; Swerdlow SH Diagn Mol Pathol; 2007 Sep; 16(3):158-68. PubMed ID: 17721324 [TBL] [Abstract][Full Text] [Related]
40. bcl-2 protein is strongly expressed in post-transplant lymphoproliferative disorders. Chetty R; Biddolph S; Kaklamanis L; Cary N; Stewart S; Giatromanolaki A; Gatter K J Pathol; 1996 Nov; 180(3):254-8. PubMed ID: 8958801 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]